GUIDES & DECKS

View all Guides & Decks

Free White Paper: The Impact of Electronic Cigarettes on the Smoking Cessation Industry

Almost 6 million adults use e-cigarettes despite the uncertainties around regulation and health consequences, according to Kantar Media’s MARS Consumer Health Study. E-cigs are quickly becoming a top competitor for both OTC and prescription smoking cessation products. This free guide gives you: A profile of the average e-cigarette user and how this person...

Download White Paper

INFOGRAPHIC

More Infographics

Point-of Care Advertising Infographic

Learn more about point-of-care advertising and its impact on consumers in our new infographic. Are adults being reached by POC media? What actions are they taking due to the advertisement? Click here to download this infographic and learn...

MORE FROM THE BLOG

Pharmacist Usage of Smartphones & Tablets Continues to Rise

by Alejandro Alvarez |  For the first time, more than half of pharmacists report using their smartphones for professional purposes, according to Kantar Media’s Sources & Interactions 2014 Study – Pharmacy Edition. Usage has... Read More

Johnson & Johnson is the Top Pharma Company Advertising in Print Medical Journals Through Q2 2014

by Client Services |  Johnson & Johnson spent almost $21 million in the first half of 2014, advertising drug products in professional health journals, according to Kantar Media. Johnson & Johnson makes up 7% of the... Read More

Pharmacists’ Internet Use for Work Reasons Remains Steady for Over Time

by Alejandro Alvarez |  Pharmacists’ internet usage for professional purposes has remained very steady since 2011, according to Kantar Media’s Sources & Interactions 2014 Study – Pharmacy Edition. The majority of pharmacists... Read More

More Than $11 Million Has Been Spent Advertising Invokana in Medical Journals Through Q2 2014

by Client Services |  Invokana is the most advertised drug products in professional health journals through Q2 2014.  Through June, more than $11 million has been spent to advertise this product, which treats Type 2... Read More

More posts